Brendan Hannah - 23 Jan 2026 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role: CBO, COO & CCO
Signature: /s/ Brendan Hannah
Issuer symbol: QNCX
Transactions as of: 23 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 23 Jan 2026, 20:05:44 UTC
Previous filing: 08 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hannah Brendan	CBO, COO & CCO	C/O QUINCE THERAPEUTICS, INC., 611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO	/s/ Brendan Hannah	23 Jan 2026	0001929422

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	QNCX	Employee Stock Option (Right to Buy)	Award	$0	-365,000	-50%	$0.000000	365,000	23 Jan 2026	Common Shares	365,000	$3.08	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting with 1/48th vesting on the date of grant and the remaining options vesting on the 1st day of each subsequent month, such that the total number of shares shall be fully vested on December 1, 2029.